Congenital Hyperinsulinism - Notes for the General Pediatrician.
Indian Pediatr
; 61(6): 578-584, 2024 Jun 15.
Article
em En
| MEDLINE
| ID: mdl-38584412
ABSTRACT
Congenital hyperinsulinism (CHI) is a rare condition but is a common cause of severe and persistent hypoglycemia in early life. Prompt recognition of CHI is critical to prevent the impact of neuroglycopenia and consequent lifelong neurodisability. It is important to be alert to the possibility of CHI in newborn babies with recurrent hypoglycemia associated with high glucose requirements. Pediatricians are advised to mitigate the risk of hypoglycemia by early treatment with high concentration dextrose and intravenous glucagon infusions. Specific medical therapies with diazoxide and/or somatostatin receptor analogues may be commenced after the finding of detectable insulin at hypoglycemia, a biochemical characteristic of CHI. Early exploration of genetic etiology is recommended, chiefly in the search for a focal form, amenable to limited pancreatic surgery. Genetic ascertainment is also useful to understand the basis of disease, variable responses to medical therapies and escalation of conservative treatment to subtotal pancreatectomy. CHI is a heterogeneous disorder with varying natural history. Many newborns and infants with CHI have severe and complex illness features; their long-term care is best achieved through review at specialist centers.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Hiperinsulinismo Congênito
Limite:
Humans
/
Infant
/
Newborn
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article